Leustatin Chemotherapy Information

As a type of chemotherapy treatment, Leustatin® (cladribine) is prescribed to treat hairy cell leukemia, a slow-growing cancer that affects the blood cells and bone marrow. It is approved for use in adults age 18 and older.
 
It comes as a liquid that is injected slowly into a vein (intravenously, or by IV) continuously over seven days. Your dosage will be determined based on how much you weigh and how you respond to the medication.
 
If your healthcare provider recommends chemotherapy treatment with Leustatin, he or she will need information on your medical history and any other medications, vitamins, or supplements you are using. Some of the potential side effects include fever, fatigue, and infections. You should also talk to your healthcare provider before starting Leustatin if you are pregnant or have any allergies.
 
(For more information about this chemotherapy medicine, click Leustatin. This full-length article explores what to expect, how the medicine works, and more.)
 
 

Leustatin Chemotherapy Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.